Wanbury Ltd Share Price
(WANBURY)
₹241.56
as on 11:24AM, 30 Apr 2025
Wanbury Ltd Performance
Day's Low
Day's High
₹236.5Day's Price Range₹248.452 Week's Low
52 Week's High
₹131.252-Week Price Range₹323.53
| Returns % | |
| 1 Month Return | -8.76 % |
| 3 Month Return | + 7.7 % |
| 1 Year Return | + 61.01 % |
| Market Stats | |
| Previous Close | ₹244.42 |
| Open | ₹248.39 |
| Volume | 52.65K |
| Upper Circuit | ₹293.30 |
| Lower Circuit | ₹195.53 |
| Market Cap | ₹800.98Cr |
Wanbury Ltd Fundamentals
P/E Ratio
18.21
PEG Ratio
2.9
Market Cap
₹800.98 Cr
P/B Ratio
21.77
EPS
17.09
Dividend Yield
0Sector
Pharmaceuticals
ROE
38.26
Key events for Wanbury Ltd
Expert Chemicals Confirms No New Share Encumbrances - 20 Apr, 2025
Expert Chemicals, a promoter of Wanbury Limited, announced no new share encumbrances for FY 2025, ensuring compliance with SEBI regulations and reinforcing market transparency.Wanbury Reports Strong Q4 Performance Amid Tariff Relief - 03 Apr, 2025
Wanbury Limited announced improved capacity utilization and margins for Q4, achieving its highest quarterly revenues. Additionally, Indian pharmaceutical imports will be exempt from upcoming US tariff hikes, benefiting the sector.Wanbury Launches New Iron Supplement and Ketamine API - 24 Mar, 2025
Wanbury Ltd is launching two new products: Wanbury C-RED, a liposomal iron supplement for improving hemoglobin levels, and Ketamine Hydrochloride API for global markets. The company aims to address significant anemia issues in India and meet the high demand for Ketamine in human and veterinary applications.
Insights on Wanbury Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, WANBURY stock has moved up by 15.9%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.84% to 1.55% in Mar 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 39.76% of holdings in Mar 2025 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 8.02 Cr → 1.22 Cr (in ₹), with an average decrease of 84.8% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 162.82 Cr → 134.29 Cr (in ₹), with an average decrease of 17.5% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 59.40% to 58.68% in Mar 2025 quarter
Wanbury Ltd Financials
Wanbury Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 39.76% | 0.00 | |
| Foreign Institutions | 1.55% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 58.68% | 0.00 | |
| Others | 0% | 0.00 |
Wanbury Ltd Key Indicators
Wanbury Ltd Valuation
Wanbury Ltd in the last 5 years
Lowest (-105.12x)
July 15, 2021
Today (18.21x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (146.91x)
September 29, 2023
Wanbury Ltd Earnings and Dividends
Wanbury Ltd Earnings Results
Wanbury Ltd’s net profit fell -88.12% since last year same period to ₹1.22Cr in the Q3 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated -84.79% fall in its net profits since last 3-months.
Read More about Earnings Results
Wanbury Ltd Technicals Summary
Bearish
Neutral
Bullish
Wanbury Ltd is currently in a Bearish trading position according to technical analysis indicators.
Wanbury Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹800.98 Cr | 196.3% | 0.91 | ₹55 Cr | ₹575 Cr | |
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
About Wanbury Ltd
Revenue: ₹133.45Cr as on December 2024 (Q4 24)
Net Profit: ₹1.22Cr as on December 2024 (Q4 24)
Listing date: 29 Jan, 2007
Chairperson Name: K Chandran
| Organisation | Wanbury Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Wanbury Ltd
What is Wanbury Ltd price today?
Wanbury Ltd share price today stands at ₹241.56, Open: ₹248.39, Previous Close: ₹244.42, High: ₹248.4, Low: ₹236.5, 52 Week High: ₹323.53, 52 Week Low: ₹131.2.
How to Buy Wanbury Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Wanbury Ltd shares
What are today's traded volumes of Wanbury Ltd?
Today's traded volume of Wanbury Ltd(WANBURY) is 52.65K.
What is today's market capitalisation of Wanbury Ltd?
Today's market capitalisation of Wanbury Ltd(WANBURY) is ₹800.98Cr.
What is the 52 Week High and Low Range of Wanbury Ltd?
How much percentage Wanbury Ltd is down from its 52 Week High?
Wanbury Ltd (WANBURY) share price is ₹241.56. It is down -25.34% from its 52 Week High price of ₹323.53
How much percentage Wanbury Ltd is up from its 52 Week low?
Wanbury Ltd (WANBURY) share price is ₹241.56. It is up 84.12% from its 52 Week Low price of ₹131.2